Development of multicomponent DNA vaccination strategies against HIV

Current Opinion in Molecular Therapeutics

Volumn 1, Issue 1, 1999, Pages 43-49

  Kim, Jong J ^a   Weiner, David B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; DNA VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; LYMPHOTOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT THERAPY; ANTIGEN EXPRESSION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; GENE TARGETING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; MOUSE; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; CHEMOKINES; CYTOKINES; HIV INFECTIONS; HUMANS; PRIMATES; SAFETY; SAIDS VACCINES; VACCINES, DNA;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032954015     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Kim JJ, Weiner DB: DNA/genetic vaccination for HIV. Springer Semin Immunopathol (1997) 19:174-195.
2. Chattergoon M, Boyer J, Weiner DB: Genetic Immunization: A new era in vaccines and Immune therapies. FASEB J (1997) 11:753-763.
3. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA: DNA Vaccines. Annu Rev Immuol (1997) 15:617-648.
4. Wang B, Ugen KE, Srikantan V, Agadjanyan MG. Dang K, Refaell Y, Sato A, Boyer J, Williams WV, Weiner DB: Gene inoculation generates Immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA (1993) 90:4156-4160.
5. Wang B, Boyer JD, Ugen KE, Srikantan V, Ayyavoo V, Agadjanyan MG, Williams WV, Newman M, Coney L, Carrano R, Weiner DB: Nucleic acid-based Immunization against HIV-1: Induction of protective in vivo Immune responses. AIDS (1995) 9:S159-S170.
6. Lu S, Santoro JC, Fuller DH, Haynes JR, Robinson HL: Use of DNAs expressing HIV-1 env and non-infectious HIV-1 particles to raise antibody responses in mice. Virology (1995) 209:147-154.
7. Haynes J, Fuller DH, Eisenbraun MD, Ford MJ, Pertmer TM: Accell® particle-mediated DNA Immunization elicits humoral, cytotoxic and protective responses. AIDS Res Hum Retroviruses (1994) 10:S43-S45.
8. Kim JJ, Ayyvoo V, Bagarazzi ML, Chattergoon MA, Dang K, Wang B, Boyer JD, Weiner DB: In vivo Engineering of a Cellular Immune Response by Co-administration of IL-12 Expression Vector with a DNA Immunogen. J Immunol (1997) 158:816-826.
9. Ayyavoo V, Nagashunmugam T, Boyer JD, Sundarasamy M, Femandes LS, Le P, Lin J, Nguyen C, Chattergoon MA, Goedert JJ, Friedman H, Weiner DB: Development of genetic vaccines for pathogenic genes: Construction of attenuated Vif DNA Immunization Cassettes. AIDS (1997) 11:1433-1444.
10. Ayyavoo V, Nagashunmugam T, Phung MT, Buckner C, Kudckodkar S, Le P, Reddy PJ, Santiago L, Patel M, Tea L, Weiner DB: Construction of attenuated HIV-1 accessory gene Immunization cassettes. Vaccine (1998) 16:1872-1879.
11. Schultz A, Hu S: Primate models for HIV vaccines. AIDS (1993) 7:5161-5170.
12. Boyer JD, Ugen KE, Wang B, Agadjanyan MG, Gilbert L, Bagarazzi M, Chattergoon M, Frost P, Javadian A, Williams WV, Refaeli Y, Ciccarelli RB, McCallus D, Coney L, Weiner DB: Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nature Med (1997) 3:526-532.
13. Boyer JD, Wang B, Ugen K, Agadjanyan MG, Javadian MA, Frost P, Dang K, Carrano R, Ciccarelli R, Coney L, Williams WV, Weiner DB: Protective anti-HIV Immune responses in non-human primates through DNA Immunization. J Med Primatol (1996) 25:242-250.
14. Letvin NL, Montefiori DC, Yasutomi Y, Perry HC, Davies M-E, Lekutis C, Alroy M, Freed DC, Lord CI, Handt LK, Liu MA, Shiver JW: Potent, protective anti-HIV Immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc Natl Acad Sci USA (1997) 94:9378-9383.
15. Putkonen P, Quesada-Rolander M, Leandersson A-C, Schwanz S, Thorstensson R, Okuda K, Wahren B, Hinkula J: Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts. Virology (1998) 250:293-301.
16. Kent SJ, Zhao A, Best SJ, Chandler JD, Boyle DB, Ramshaw LA: Enhanced T-cell Immunogenicity and protective efficacy of a human Immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J Virol (1998) 72:10180-10188.
17. Lu S, Arthos J, Montefiori DC, Yasutomi Y, Manson K, Mustafa F, Johnson E, Santoro JC, Wissink J, Mullins JI, Haynes JR, Letvin NL, Wyand M, Robinson HL: Simian immunodeficiency virus DNA vaccine trial in macaques. J Virology (1996) 70:3978-3991.
18. MacGregor RR, Boyer JD, Ugen KE, Lacy K, Gluckman S, Bagarazzi ML, Chattergoon M, Baine.Y, Higgins TJ, Ciccarelli RB, Coney LR, Ginsberg RS, Weiner DB: First human trial of a facilitated DNA plasmid vaccine for HIV-1: Safety and host response. J Inf Dis (1998) 176:92-100.
19. Wang R, Doolan DL, Le TP, Hedstrom RC, Coonan KM, Charoenvit Y, Jones TR, Hobart P, Margalith M, Ng J, Weiss WR, Sedegah M, de Taisne C, Norman JA, Huffman SL Induction of antigen-specific cytotoxic T-lymphocytes in humans by a malaria DNA vaccine. Science (1998) 282:476-480.
20. Kim JJ, Ayyavoo V, Bagarazzi ML, Chattergoon M, Boyer JD, Wang B, Weiner DB: Development of a multi-component candidate vaccine for HIV-1. Vaccine (1997) 15:879-883.
21. Kim JJ, Trivedi NN, Nottingham L, Morrison L, Tsai A, Hu Y, Mahalingam S, Dang K, Ahn L, Doyle NK, Wilson DM, Chattergoon MA, Challan AA, Boyer JD, Agadjanyan MG, Weiner DB: Modulation of amplitude and direction of in vivo Immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur J Immunol (1998) 28:1089-1103.
22. Kim JJ, Maguire HC Jr, Nottingham LK, Morrison LD, Tsai A, Sin JI, Chalian AA, Weiner DB: Co-administration of IL-12 or IL-10 expression cassettes drives Immune responses towards a Th1 phenotype. J Interf Cyto Res (1998) 18:537-547.
23. Kim JJ, Nottingham LK, Sin JI, Tsai A, Morrison L, Oh J, Dang K, Hu Y, Kazahaya K, Bennett M, Dentchev T, Wilson DM, Chalian AA, Boyer JD, Agadjanyan MG, Weiner DB: CD8 positive T cells controls antigen-specific Immune responses through the expression of chemokines. J Clin Invest (1998) 102:1112-1124.
24. Kim JJ, Bagarazzi ML, Trivedi N, Hu Y, Chattergoon MA, Dang K, Mahalingam S, Agadjanyan MG, Boyer JD, Wang B, Weiner DB: Engineering of in vivo Immune responses to DNA Immunization via co-delivery of costimulatory molecule genes. Nature Biol (1997) 15:641-645.
25. Chow Y-H, Huang W-L, Chi W-K, Chu Y-D, Tao M-H: Improvement of hepatitis B virus DNA vaccines by plasmlds coexpressing hepatitis B surface antigen and interleukin-2. J Virol (1997) 71:169-178.
26. Iwasaki A, Stiemholm BJ, Chan AK, Berstein NL, Barber BH: Enhanced CTL responses mediated by plasmid DNA Immunogens encoding costimulatory molecules and cytokines. J Immunol (1987) 158:4591-4601.
27. Tsuji T, Hamajima K, Ishii N, Aoki I, Fukushima J, Xin KQ, Kawamoto S, Sasaki S, Matsunaga K, Ishigatsubo Y, Tani K, Okubo T, Okuda K: Immunomodulatory effects of a plasmid expressing B7-2 on human Immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen. Euro J Immuno (1997) 27:782-787.
28. Xiang Z, Ertl HC: Manipulation of the Immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity (1995) 2:129-135.
29. Sin JI, Kim JJ, Boyer JD, Huggins C, Higgins T, Weiner DB: in vivo modulation of Immune responses and protective Immunity against herpes simplex virus-2 Infection using cDNAs expressing Th1 and Th2 type cytokines in gD DNA vaccination. J Virol (1998).
30. Schwarte RH: Costimulatlon of T-lymphocytes: The role of CD29, CTLA-4, and B7/BB1 in interleukin-2 production and Immunotherapy. Cell (1992) 71:1065-1068.
31. Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, Azuma M: CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T-cell proliferation, cytokine production, and generation of CTL. J Immunol (1995) 154:97-105.
32. Linsley PS, Clark EA, Ledbetter JA: The T cell antigen, CD28, mediates adhesion with B cells by interacting with activation antigen, B7/BB-1. Proc Natl Acad Sci USA (1990) 87:5031-5035.
33. June C, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor families. Immunol Today (1994) 15:321-333.
34. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, Walker BD: Vigorous HIV-1-specific CD4+T-cell responses associated with control of viremia. Science (1997) 278:1447-1450.
35. Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Cerundolo V, Hurley A, Markowitz M, Ho DD, Nixon DF, McMichael AJ: Quantitation of HIV-1-specific cytotoxic T-lymphocytes and plasma load of viral RNA. Science (1998) 279:2103-2106.
36. Lekutis C, Shiver JW, Liu MA, Letvin NL: HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class IL-restricted CD4+ T-helper cells that secrete IFN-gamma and TNF-alpha. J Immunol (1997) 158:4471-4477.